Goodwin advised the initial purchasers on Amphastar Pharmaceuticals, Inc.’s offering.Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced the Rule 144A offering of 2.00% Convertible Senior Notes due 2029. …
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
